Acetaminophen Extended Release (Tylenol 8HR)

Analgesicoral · predicted

Bilayer 650 mg acetaminophen tablet containing 325 mg immediate-release and 325 mg extended-release drug for up to 8 hours of relief. Do not crush, chew, split, or dissolve the tablet.

Projected serum levels — 1.3k mg, as needed (shown daily)

Acetaminophen Extended Release (Tylenol 8HR)
Acetaminophen Extended Release (Tylenol 8HR) modeled serum levels, 1.3k mg as needed (shown daily) over 15 days Population-based pharmacokinetic estimate. Steady state reached after approximately 1 days. 0 250 500 750 1k Day 0 Day 4 Day 8 Day 11 Day 15 Time on a regular schedule ≈ steady state · day 1

Maintenance schedule: 1.3k mg as needed (shown daily) (oral).

Modeled steady state after ~1 days: peak ≈ 550 mg, trough ≈ 2.0 mg body load. Population-based estimate over 15 days for a 1.3k mg dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.

Key facts

Category
Analgesic
Route modeled
Oral
Model confidence
predicted
Half-life
2.3 h
Common dose
1.3k mg
Suggested maximum
3.9k mg/day
Reference dose range
650–3.9k mg (single dose)
Suggested cadence
as needed (shown daily)

Research behind this entry

  1. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials Machado GC et al. · BMJ, 2015 DOI

    Meta-analysis found paracetamol was ineffective for low back pain and provided only small, clinically insignificant benefits for osteoarthritis pain and disability.

  2. Acetaminophen-induced hepatotoxicity: a comprehensive update Yoon E et al. · Journal of Clinical and Translational Hepatology, 2016 DOI

    Review establishing acetaminophen overdose as the leading cause of acute liver failure in the US, detailing the NAPQI toxicity mechanism and NAC treatment.

  3. Paracetamol: not as safe as we thought? A systematic review of observational studies Roberts E et al. · Annals of the Rheumatic Diseases, 2016 DOI

    Systematic review found dose-response relationship between paracetamol use and adverse events including increased cardiovascular, GI, and renal risks at higher doses.

3 published studies referenced in the app, each with a plain-language summary.